For years, pulmonologists and allergists have treated asthma exacerbations as events triggered by allergens, viruses, or pollutants. We manage inflammation with inhaled corticosteroids and rescue pati…
The first time I watched a robotic bronchoscope navigate a subsegmental airway I had only ever seen on a CT scan, I felt the ground shift under my feet. For years, we accepted that peripheral lung les…
The pressure to deliver effective oxygen therapy in high-acuity settings has never been greater. Whether you are managing a patient with COVID-19, ARDS, or acute hypoxemic respiratory failure, the too…
For pulmonologists and infectious disease specialists, staying current with non-tuberculous mycobacterial lung disease management updates 2026 is no small task. The field is moving faster than it has …
You are in the ICU. A 58 year old patient with sepsis just developed worsening hypoxemia. The chest X-ray shows bilateral infiltrates. You start lung protective ventilation, but something deeper is ha…
When a newborn struggles to take their first breath, or an adult with ARDS fights against stiff, fluid-filled lungs, the missing piece is often the same: surfactant. This natural substance, a complex …
When a patient with severe pneumonia arrives in the ICU, every hour counts. Standard cultures can take days. They often miss fastidious or atypical organisms. You know the frustration of a negative cu…
Pulmonary hypertension (PH) puts a heavy load on the right ventricle. Over time, that chamber struggles to keep up. The heart muscle thickens, the chamber dilates, and eventually it fails. Catching th…
Key Takeaway Anti-IL-33 biologics represent a promising new frontier for refractory COPD, especially for patients with low type 2 inflammation who do not respond to existing treatments. Phase III data…
